Howard A. Burris III, MD | Authors

SUNCOAST INTERNAL MEDICINE CONSULTANTS

13644 WALSINGHAM RD

Articles

Gemcitabine, Paclitaxel, and Carboplatin for Advanced Non–Small-Cell Lung Cancer

July 01, 2000

The purpose of this study was to evaluate the combination of gemcitabine (Gemzar), paclitaxel (Taxol), and carboplatin (Paraplatin) in patients with advanced non–small-cell lung cancer (NSCLC). Previously untreated

Docetaxel in Combination With Fluorouracil for Advanced Solid Tumors

August 01, 1997

The results from preclinical studies using murine tumor models show that the combination of docetaxel (Taxotere) and fluorouracil (5-FU) is highly synergistic. Phase I studies in patients

Docetaxel in Combination With Flourouracil: Study Design and Preliminary Results

June 01, 1997

The relatively recent introduction of a new class of chemotherapeutic agents--the taxoids--has raised hope of improved survival for patients with advanced or metastatic cancer. Following encouraging preclinical results of taxoid combinations, this phase I, nonrandomized trial was designed to evaluate a 1-hour intravenous infusion of docetaxel (Taxotere) on day 1 combined with fluorouracil (5-FU) as a daily intravenous bolus for 5 consecutive days.